Skip to main content

Genmab A/S

GNMSF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001434265

No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesGMAB

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding GNMSF, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GNMSF at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Genmab A/S insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Genmab A/S insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Genmab A/S at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding GNMSF in 13F filings for Q2 2026.